SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-17-000004
Filing Date
2017-05-08
Accepted
2017-05-08 17:30:45
Documents
67
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q egrx_q1x2017.htm 10-Q 789163
2 EXHIBIT 31.1 exhibit311q12017.htm EX-31.1 9695
3 EXHIBIT 31.2 exhibit312q12017.htm EX-31.2 9658
4 EXHIBIT 32.1 exhibit321q12017.htm EX-32.1 10010
  Complete submission text file 0000827871-17-000004.txt   5135243

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT egrx-20170331.xml EX-101.INS 868520
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20170331.xsd EX-101.SCH 42376
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20170331_cal.xml EX-101.CAL 92574
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20170331_def.xml EX-101.DEF 227085
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20170331_lab.xml EX-101.LAB 585613
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20170331_pre.xml EX-101.PRE 375167
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 17823614
SIC: 2834 Pharmaceutical Preparations